These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 20020131)

  • 1. Etanercept and anakinra can prolong febrile episodes in patients with hyperimmunoglobulin D and periodic fever syndrome.
    Shendi HM; Walsh D; Edgar JD
    Rheumatol Int; 2012 Jan; 32(1):249-51. PubMed ID: 20020131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin 6 blockade for hyperimmunoglobulin D and periodic fever syndrome.
    Shendi HM; Devlin LA; Edgar JD
    J Clin Rheumatol; 2014 Mar; 20(2):103-5. PubMed ID: 24561416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperimmunoglobulinemia D and periodic fever syndrome; treatment with etanercept and follow-up.
    Topaloğlu R; Ayaz NA; Waterham HR; Yüce A; Gumruk F; Sanal O
    Clin Rheumatol; 2008 Oct; 27(10):1317-20. PubMed ID: 18506569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term follow-up, clinical features, and quality of life in a series of 103 patients with hyperimmunoglobulinemia D syndrome.
    van der Hilst JCH; Bodar EJ; Barron KS; Frenkel J; Drenth JPH; van der Meer JWM; Simon A;
    Medicine (Baltimore); 2008 Nov; 87(6):301-310. PubMed ID: 19011501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperimmunoglobulin D syndrome in childhood.
    van der Hilst JC; Frenkel J
    Curr Rheumatol Rep; 2010 Apr; 12(2):101-7. PubMed ID: 20425018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment with anakinra in the hyperimmunoglobulinemia D/periodic fever syndrome.
    Rigante D; Ansuini V; Bertoni B; Pugliese AL; Avallone L; Federico G; Stabile A
    Rheumatol Int; 2006 Nov; 27(1):97-100. PubMed ID: 16871408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-interleukin 1 treatment for patients with familial Mediterranean fever resistant to colchicine.
    Ozen S; Bilginer Y; Aktay Ayaz N; Calguneri M
    J Rheumatol; 2011 Mar; 38(3):516-8. PubMed ID: 21159830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term efficacy of canakinumab in hyperimmunoglobulin D syndrome.
    Ozdemir Isik O; Karadag DT; Tekeoglu S; Yazici A; Cefle K; Cefle A
    Int J Rheum Dis; 2024 Jan; 27(1):e14857. PubMed ID: 37578023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mevalonate kinase deficiency in two sisters with therapeutic response to anakinra: case report and review of the literature.
    Campanilho-Marques R; Brogan PA
    Clin Rheumatol; 2014 Nov; 33(11):1681-4. PubMed ID: 24531849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On-demand anakinra treatment is effective in mevalonate kinase deficiency.
    Bodar EJ; Kuijk LM; Drenth JP; van der Meer JW; Simon A; Frenkel J
    Ann Rheum Dis; 2011 Dec; 70(12):2155-8. PubMed ID: 21859689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. International Retrospective Chart Review of Treatment Patterns in Severe Familial Mediterranean Fever, Tumor Necrosis Factor Receptor-Associated Periodic Syndrome, and Mevalonate Kinase Deficiency/Hyperimmunoglobulinemia D Syndrome.
    Ozen S; Kuemmerle-Deschner JB; Cimaz R; Livneh A; Quartier P; Kone-Paut I; Zeft A; Spalding S; Gul A; Hentgen V; Savic S; Foeldvari I; Frenkel J; Cantarini L; Patel D; Weiss J; Marinsek N; Degun R; Lomax KG; Lachmann HJ
    Arthritis Care Res (Hoboken); 2017 Apr; 69(4):578-586. PubMed ID: 27723279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of etanercept and anakinra on inflammatory attacks in the hyper-IgD syndrome: introducing a vaccination provocation model.
    Bodar EJ; van der Hilst JC; Drenth JP; van der Meer JW; Simon A
    Neth J Med; 2005; 63(7):260-4. PubMed ID: 16093577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consensus protocols for the diagnosis and management of the hereditary autoinflammatory syndromes CAPS, TRAPS and MKD/HIDS: a German PRO-KIND initiative.
    Hansmann S; Lainka E; Horneff G; Holzinger D; Rieber N; Jansson AF; Rösen-Wolff A; Erbis G; Prelog M; Brunner J; Benseler SM; Kuemmerle-Deschner JB
    Pediatr Rheumatol Online J; 2020 Feb; 18(1):17. PubMed ID: 32066461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperimmunoglobulinemia D and periodic fever syndrome in children. Review on therapy with biological drugs and case report.
    Korppi M; Van Gijn ME; Antila K
    Acta Paediatr; 2011 Jan; 100(1):21-5. PubMed ID: 20712835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Failure of sustained response to etanercept and refractoriness to anakinra in patients with T50M TNF-receptor-associated periodic syndrome.
    Quillinan N; Mannion G; Mohammad A; Coughlan R; Dickie LJ; McDermott MF; McGonagle D
    Ann Rheum Dis; 2011 Sep; 70(9):1692-3. PubMed ID: 21378401
    [No Abstract]   [Full Text] [Related]  

  • 16. A systematic review of the off-label use of biological therapies in systemic autoimmune diseases.
    Ramos-Casals M; Brito-Zerón P; Muñoz S; Soto MJ;
    Medicine (Baltimore); 2008 Nov; 87(6):345-364. PubMed ID: 19011506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic literature review of efficacy/effectiveness and safety of current therapies for the treatment of cryopyrin-associated periodic syndrome, hyperimmunoglobulin D syndrome and tumour necrosis factor receptor-associated periodic syndrome.
    Kuemmerle-Deschner JB; Gautam R; George AT; Raza S; Lomax KG; Hur P
    RMD Open; 2020 Jul; 6(2):. PubMed ID: 32723831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrent macrophage activation syndrome due to hyperimmunoglobulin D syndrome: a case-based review.
    Gezgin Yıldırım D; Yıldız Yıldırım Ç; Karaçayır N; Esmeray Şenol P; Sunar Yayla EN; Bakkaloğlu SA
    Clin Rheumatol; 2023 Jan; 42(1):277-283. PubMed ID: 36149537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor necrosis factor receptor 1-associated periodic syndrome without fever: cytokine profile before and during etanercept treatment.
    Morbach H; Richl P; Stojanov S; Lohse P; Girschick HJ
    Rheumatol Int; 2009 Dec; 30(2):207-12. PubMed ID: 19381634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A network meta-analysis of randomized controlled trials of biologics for rheumatoid arthritis: a Cochrane overview.
    Singh JA; Christensen R; Wells GA; Suarez-Almazor ME; Buchbinder R; Lopez-Olivo MA; Ghogomu ET; Tugwell P
    CMAJ; 2009 Nov; 181(11):787-96. PubMed ID: 19884297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.